Cover Image
市場調查報告書

歐洲的胰島素筆針市場

European Market Report for Insulin Pens 2016 - MedCore

出版商 iData Research Inc. 商品編碼 370969
出版日期 內容資訊 英文 96 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的胰島素筆針市場 European Market Report for Insulin Pens 2016 - MedCore
出版日期: 2016年09月01日 內容資訊: 英文 96 Pages
簡介

本報告提供歐洲的胰島素筆針市場相關調查分析,提供您市場概要,市場分析與預測,推動因素·阻礙因素,競爭分析等系統性資訊。

第1章 調查手法

第2章 疾病概要

  • 簡介
    • 糖尿病的種類
    • 糖尿病的併發症
    • 第一型·第二型糖尿病相關的危險因素
    • 徵兆與症狀
    • 糖尿病監測
    • 治療
    • 藥物遞輸系統

第3章 國家概況

  • 簡介
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷比盧三國
  • 北歐各國
  • 奧地利
  • 瑞士
  • 葡萄牙

第4章 胰島素筆針市場

  • 簡介
  • 市場概要
  • 市場分析與預測
  • 推動因素·阻礙因素
    • 推動市場要素
    • 市場阻礙因素
  • 競爭市場佔有率分析

簡稱

目錄
Product Code: iDATA_EUDD16_MC_PEN

The total European market for insulin pens comprises the prefilled pen segment, the pen cartridge segment, the pen needle segment and the safety pen needle segment. In 2015, the largest segment in the total insulin pen market was the prefilled pen segment, which represented over 80% of the total market value. Prefilled pens account for such a large portion of the market because they are highly preferred to reusable pens by diabetic patients. It is expected that this trend will continue over the forecast period, as reusable pens do not offer a financial incentive and essentially perform the same function as prefilled pens. Growth of the segment will be driven by unit sales growth and modest ASP appreciation of the overall insulin market.

Insulin pens are shaped like a writing pen, but have a reservoir for insulin and are used as a delivery method for insulin. To administer insulin, patients must remove the pen cap, clean the injection site with an alcohol swab, attach a pen needle, prime the pen, dial the appropriate dosage amount and finally inject the insulin. There is a dose dial on the side of the pen so the patient can choose the required dose.

Insulin pens are either prefilled or reusable with a disposable cartridge component, and generally carry 300 units of insulin. Most brands of insulin are available in pen format. This delivery method offers several advantages over the traditional vial and syringe delivery method. Pens offer ease-of-handling, improved accuracy, more discreet use and less injection pain.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN MARKET FOR DIABETES MONITORING, TREATMENT AND DRUG DELIVERY

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1 RESEARCH SCOPE
  • 1.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1 INTRODUCTION
    • 2.1.1 Types of Diabetes
    • 2.1.2 Diabetes Complications
    • 2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
    • 2.1.4 Signs and Symptoms
    • 2.1.5 Diabetes Monitoring
    • 2.1.6 Treatment
    • 2.1.7 Drug Delivery Systems

COUNTRY PROFILES

  • 3.1 INTRODUCTION
    • 3.1.1.1 Population
    • 3.1.1.2 GDP Per Capita
    • 3.1.1.3 Units
  • 3.2 GERMANY
  • 3.3 FRANCE
  • 3.4 UNITED KINGDOM
  • 3.5 ITALY
  • 3.6 SPAIN
  • 3.7 BENELUX
  • 3.8 SCANDINAVIA
  • 3.9 AUSTRIA
  • 3.10 SWITZERLAND
  • 3.11 PORTUGAL

INSULIN PEN MARKET

  • 4.1 INTRODUCTION
  • 4.2 MARKET OVERVIEW
  • 4.3 MARKET ANALYSIS AND FORECAST
    • 4.3.1 Total Insulin Pen Market
    • 4.3.2 Prefilled Insulin Pen Market
    • 4.3.3 Insulin Pen Cartridge Market
    • 4.3.4 Insulin Pen Needle Market
    • 4.3.5 Safety Insulin Pen Needle Market
  • 4.4 DRIVERS AND LIMITERS
    • 4.4.1 Market Drivers
    • 4.4.2 Market Limiters
  • 4.5 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

Back to Top